Dynamic microglia alterations associate with hippocampal network impairments: A turning point in amyloid pathology

Giusy Pizzirusso1, Efthalia Preka2, Julen Goikolea3

  • 1Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Sweden; Department of Women's and Children's Health, Karolinska Institutet, Sweden.

PubMed

Insights

Microglia protect the brain in early Alzheimer's disease by reducing amyloid plaques and preserving neural network function. Altered microglia activity may drive disease progression, impacting memory and cognition.

Area of Science:

  • Neuroscience
  • Neuroinflammation
  • Alzheimer's Disease Research

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline.
  • The precise mechanisms driving AD pathogenesis, particularly in its early stages, remain incompletely understood, hindering effective prevention and treatment strategies.
  • Emerging evidence implicates neuroinflammation, especially the role of microglia, in AD onset and progression.

Purpose of the Study:

  • To investigate the transition from pre-plaque to early plaque stages in a mouse model of Alzheimer's disease.
  • To characterize the functional and molecular changes associated with early amyloid pathology.
  • To elucidate the role of microglia in the initial phases of Alzheimer's disease.

Main Methods:

  • Utilized the AppNL-G-F knock-in mouse model, which recapitulates key AD pathologies.
  • Employed a combined functional (electrophysiology) and molecular (transcriptomics) approach.
  • Analyzed hippocampal gamma oscillations, interneuron properties, synaptic pathways, and microglial gene expression and markers (Iba1).

Main Results:

  • Observed a progressive decline in hippocampal gamma oscillations during early amyloid pathology.
  • Detected modifications in fast-spiking interneuron properties and synaptic function-associated pathways.
  • Found downregulation of homeostasis- and inflammatory-related microglia genes and a decrease in Iba1-positive microglia correlating with plaque aggregation and neuronal dysfunction.

Conclusions:

  • Microglia appear to play a protective role in early AD by limiting plaque formation and maintaining neuronal homeostasis and network function.
  • Early alterations in microglial dynamics may be a critical factor in AD progression, leading to plaque deposition and cognitive deficits.
  • Targeting early microglial activity could offer novel therapeutic strategies for Alzheimer's disease.